Optimizing the Long-Term Therapy with Eculizumab (ECU) for Atypical Hemolytic Uremic Syndrome (aHUS).

Indian J Pediatr

Unit of Clinical Pathology, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, Viale Luigi Pinto, 71122, Foggia, Italy.

Published: February 2024

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12098-023-04817-0DOI Listing

Publication Analysis

Top Keywords

optimizing long-term
4
long-term therapy
4
therapy eculizumab
4
eculizumab ecu
4
ecu atypical
4
atypical hemolytic
4
hemolytic uremic
4
uremic syndrome
4
syndrome ahus
4
optimizing
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!